Is it effective to use Augmentin (amoxicillin-clavulanate) and Keflex (cephalexin) together to treat a skin infection in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Using Augmentin and Keflex Together for Skin Infection

Combining Augmentin (amoxicillin-clavulanate) and Keflex (cephalexin) for skin infections is unnecessary and represents inappropriate polypharmacy—you should use one beta-lactam agent, not both simultaneously. 1

Why Combination is Inappropriate

Both Augmentin and Keflex are beta-lactam antibiotics with overlapping spectra of activity against the primary pathogens in skin infections: beta-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus (MSSA). 2, 1 Using both agents together provides no additional antimicrobial coverage beyond what either agent achieves alone, while doubling the risk of adverse effects and unnecessarily increasing antibiotic exposure. 1

Beta-lactam monotherapy is the standard of care for typical uncomplicated cellulitis, with a 96% success rate. 1 The Infectious Diseases Society of America explicitly recommends single-agent therapy with penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, or clindamycin for nonpurulent cellulitis. 2, 1

Choosing Between Augmentin and Keflex

When to Use Keflex (Cephalexin)

Use cephalexin 500 mg orally every 6 hours for typical nonpurulent cellulitis without specific risk factors. 1 Cephalexin provides excellent coverage against streptococci and MSSA, which are the primary pathogens in 96% of typical cellulitis cases. 1, 3 Cephalexin has demonstrated cure rates of 90% or higher in streptococcal and staphylococcal skin infections over 12 years of clinical experience. 3

Cephalexin is appropriate when:

  • The cellulitis is nonpurulent (no drainage or exudate) 1
  • No MRSA risk factors are present (no penetrating trauma, injection drug use, or known MRSA colonization) 1
  • No systemic inflammatory response syndrome (SIRS) is present 1

When to Use Augmentin (Amoxicillin-Clavulanate)

Use Augmentin 875/125 mg twice daily specifically for bite-associated cellulitis (animal or human bites). 2, 1 Augmentin provides single-agent coverage for the polymicrobial oral flora commonly found in bite wounds, including Pasteurella multocida and anaerobes. 2

Augmentin is appropriate when:

  • The infection is associated with an animal or human bite 2, 1
  • Polymicrobial coverage including anaerobes is needed 2
  • The patient cannot take other beta-lactams due to specific contraindications 2

Treatment Duration

Treat for 5 days if clinical improvement occurs; extend only if symptoms have not improved within this timeframe. 1 This applies to both cephalexin and Augmentin when used appropriately. 1 Traditional 7-14 day courses are no longer necessary for uncomplicated cases. 1

When MRSA Coverage is Actually Needed

If MRSA coverage is required (penetrating trauma, purulent drainage, injection drug use, or MRSA risk factors), neither Augmentin nor Keflex alone is adequate. 1 In these scenarios:

  • Use clindamycin 300-450 mg orally four times daily as monotherapy (covers both streptococci and MRSA) 1, 4
  • Or combine trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily PLUS a beta-lactam 1
  • Or use doxycycline 100 mg twice daily PLUS a beta-lactam 1

Common Pitfall to Avoid

Do not combine multiple antibiotics when monotherapy is appropriate, as this increases adverse effects without improving outcomes. 1 The reflexive addition of multiple agents represents overtreatment and contributes to antibiotic resistance. 1 Choose the single most appropriate agent based on the specific clinical scenario—bite wound versus typical cellulitis—and use that agent alone. 1

References

Guideline

Management of Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Alternative Antibiotics for Skin Infections in Amoxicillin-Allergic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.